Ask Warren

Dong-A Pharmaceutical

000640 · KOSPI · ₩000640 · 동아제약

₩86,300▼ ₩1,300 (1.48%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −22.60%
STOP ₩92,100DCA3 ₩92,000DCA2 ₩90,700DCA1 ₩89,300Entry ₩87,900✅ TP1 ₩85,100TP2 ₩82,400TP3 ₩78,200TP4 ₩74,100TP5 ₩65,800
Entry, trailing stop, targets and DCA levels of the current Squeeze! setup (paper-trading levels from a fixed rule, not advice).
Market cap
₩581B
Enterprise value
₩936B
P/E
6.8×
P/B
0.5×
Dividend yield
2.0%
ROE
7.1%
Net margin
5.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−31.2% from the high

₩74,500Today: ₩84,900 – ₩88,900₩125,500

Returns

  • 1W−4.9%
  • 1M−8.7%
  • 3M+0.6%
  • 6M−11.8%
  • YTD−21.3%
  • 1Y−22.6%
Volume today
8,902
0.8× the 20-day average
Traded today
₩763M
Listed shares
6,732,527
EPS (12 months)
₩12,662
Earnings yield 14.7%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

39Quiet
  • BuzzQuietBuzz 39 of 100 (50 is a normal day for this stock).
  • SentimentPositiveNews: Headlines highlight record quarterly sales and profit growth. Community: 0 bullish, 0 bearish posts this week.
  • MomentumWeak-8.2% over the last month; the price is below its 20-day average.
  • News impactSome17 news items and filings in two weeks; 0 rated high impact, 1 medium.

Signals describe activity, not recommendations. Not financial advice.

Dong-A Pharmaceutical stock overview

Dong-A Pharmaceutical (동아제약, KRX: 000640) is listed on KOSPI, in the Holding companies sector. The company is a holding company that manages six reporting segments: general medicines and quasi-drugs (including Bacchus and Ssorimol-type consumer health products), biosimilars and contract manufacturing of pharmaceuticals, logistics (freight, parcel delivery, automobile transport, and warehousing), packaging containers and bottled water (glass containers, beverages, and mineral water), and other businesses such as IT solutions and real estate development. Its shares closed at ₩86,300 on Oct 29, 2026, down 1.48% on the day, giving it a market value of ₩581B.

Key facts

Market cap
₩581B
Sector
Holding companies
Latest price change
−1.48%
As of
Oct 29, 2026
Main business
The company is a holding company that manages six reporting segments: general medicines and quasi-drugs (including Bacchus and Ssorimol-type consumer health products), biosimilars and contract manufacturing of pharmaceuticals, logistics (freight, parcel delivery, automobile transport, and warehousing), packaging containers and bottled water (glass containers, beverages, and mineral water), and other businesses such as IT solutions and real estate development.

Quick answers about Dong-A Pharmaceutical

What does Dong-A Pharmaceutical do?
The company is a holding company that manages six reporting segments: general medicines and quasi-drugs (including Bacchus and Ssorimol-type consumer health products), biosimilars and contract manufacturing of pharmaceuticals, logistics (freight, parcel delivery, automobile transport, and warehousing), packaging containers and bottled water (glass containers, beverages, and mineral water), and other businesses such as IT solutions and real estate development. Its general medicines segment sells products such as Bacchus and Orsomol, while its logistics segment provides delivery, transport, and international forwarding services. The company operates production facilities, including plants in Cheonan and Dangjin, and its packaging segment supplies glass bottles, caps, and cases.
What is the market cap of Dong-A Pharmaceutical?
The market capitalisation of Dong-A Pharmaceutical was ₩581B at the close on Oct 29, 2026.
Who are the largest shareholders of Dong-A Pharmaceutical?
According to the latest official filings, the largest reported holders are Kang Jeong-seok (42.54%, as of Sep 2, 2026); National Pension Service (9.45%, as of Oct 2, 2026); Bearing Asset Management (6.36%, as of Jan 9, 2026).
When is the next earnings report from Dong-A Pharmaceutical?
Korean companies rarely announce results dates in advance. Based on when Dong-A Pharmaceutical filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own Dong-A Pharmaceutical?
Yes. The National Pension Service held 9.45% of Dong-A Pharmaceutical shares as of Oct 2, 2026.

Company profile

The company is a holding company that manages six reporting segments: general medicines and quasi-drugs (including Bacchus and Ssorimol-type consumer health products), biosimilars and contract manufacturing of pharmaceuticals, logistics (freight, parcel delivery, automobile transport, and warehousing), packaging containers and bottled water (glass containers, beverages, and mineral water), and other businesses such as IT solutions and real estate development. Its general medicines segment sells products such as Bacchus and Orsomol, while its logistics segment provides delivery, transport, and international forwarding services. The company operates production facilities, including plants in Cheonan and Dangjin, and its packaging segment supplies glass bottles, caps, and cases.

Written by AI from the company's latest annual report.

Korean name
동아제약
Sector
Holding companies
Themes
Biotech (new drugs)Pharmaceuticals
CEO
김민영
Founded
Aug 1949
Listed
Feb 1970
Listed shares
6,732,527
Fiscal year ends
Month 12
Website
www.donga.co.kr

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Dong-A Pharmaceutical / 동아제약 / 000640 / KRX:000640

Source: KRX statistical information